Multi-omics analysis of intestinal organoids demonstrated that following mutation acquisition, tumor-initiating LGR5+ stem cells begin expressing the transcription factor SOX17 (76), initiating a developmental regulatory program associated with fetal intestinal development. This evidence concerns the gene SOX17 and neoplasm.